Well then, if you'd rather not resemble the Monty Python definition of someone who isn't a king, Clean Vanilla ... Yaga and the Labyrinth sends you off to an interdimensional maze to rescue ...

“Then your toothache, my dear child,” the aunt said so softly as if she was afraid some evil forces were lurking in the dark to eavesdrop on what she was about to utter. “Your toothache is not a real ...

Imagine a place where you can spend an entire day exploring, discovering hidden gems, and reliving memories from decades past ...

Hidden in the heart of Pennsauken, New Jersey, lies a thrifter’s dream come true – a place where time seems to stand still, ...

Facing the rune, move to the right, don't turn around and walk forward, simply move right while facing forward and you'll be ...

The board game Labyrinth is an all-time classic, first published by Ravensburger and Max J. Kobbert back in 1986. Since then, ...

Maze Therapeutics has set out plans for a $131 million IPO as the company prepares to start dosing its lead kidney drug in a phase 2 trial. The Bay Area-based biotech unveiled its ambition earlier ...

Obesity biotech Metsera and renal and metabolic-focused Maze Therapeutics have met their IPO expectations as the two companies prepare to join the Nasdaq this morning. While Metsera is offering ...

Maze seeks as much as $133 mln in New York IPO Backers include Alphabet's GV and Third Rock Ventures Biotech IPOs set for ramp up in coming weeks Jan 27 (Reuters) - Drug developer Maze ...